Oracle
ORCL
NVIDIA
NVDA
Amazon
AMZN
Adobe
ADBE
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
AUPH Aurinia Pharmaceuticals
- 7.730
- -0.280-3.50%
Close Jan 21 16:00 ET
- 7.690
- -0.040-0.52%
Post 16:59 ET
1.11BMarket Cap-51.53P/E (TTM)
8.190High7.690Low1.79MVolume8.070Open8.010Pre Close13.99MTurnover1.36%Turnover RatioLossP/E (Static)143.18MShares10.67052wk High2.85P/B1.02BFloat Cap4.71052wk Low--Dividend TTM131.70MShs Float33.972Historical High--Div YieldTTM6.24%Amplitude1.000Historical Low7.814Avg Price1Lot Size
Aurinia Pharmaceuticals Key Stats
EPS
According to the latest financial report of Aurinia Pharmaceuticals, the latest earnings per share (TTM) for the company is 0.10. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Aurinia Pharmaceuticals's free cash flow? The latest report shows it as 16.90M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Aurinia Pharmaceuticals shows that the company's current ratio is 5.60, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Aurinia Pharmaceuticals, the quick ratio is 4.90, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Aurinia Pharmaceuticals? The latest ROE figure is 3.81%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Aurinia Pharmaceuticals, the total asset return on investment (ROA) is 2.68%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Aurinia Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 91.10%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Aurinia Pharmaceuticals, the net profit margin is 21.17%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.